We observed high protein expression of LSD1 in prostate cancer cells (Fig 1A, 5A), and the inhibition of LSD1 activity using NCL1 reduced cell proliferation in vitro (Fig. 1C, 2D, 4E). Here, CAPN3 is linked to prostate carcinoma.